Search Results - "Hallucinogens therapeutic use"

Use of psychedelic treatments in psychiatric clinical practice:an EPA policy paper

Authors: Destoop, M. Mohr, P Butlen, F et al.

Source: Destoop, M, Mohr, P, Butlen, F, Kéri, P, Samochowiec, J, De Picker, L, Fiorillo, A, Kuypers, K P C & Dom, G 2025, 'Use of psychedelic treatments in psychiatric clinical practice : an EPA policy paper', European Psychiatry, vol. 68, no. 1, e3. https://doi.org/10.1192/j.eurpsy.2024.1806

Subject Terms: DMT, LSD, Psychedelics, mental health, methodological challenges, psilocybin, psychiatric disorders, Humans, Hallucinogens/therapeutic use, Mental Disorders/drug therapy, Psychiatry, Europe, Psilocybin/therapeutic use pharmacology

Relation: info:eu-repo/semantics/altIdentifier/pissn/0924-9338; info:eu-repo/semantics/altIdentifier/eissn/1778-3585

Availability: https://cris.maastrichtuniversity.nl/en/publications/6566a64e-f598-4506-9b4c-c2182c4823f6
https://doi.org/10.1192/j.eurpsy.2024.1806
https://www.scopus.com/pages/publications/85214906699

Psychédéliques dans le domaine de la douleur chronique. Une piste à explorer?

Authors: Molinard-Chenu, Aude Tsimploulis, Georgios Penzenstadler, Louise Emilie et al.

Source: Revue Médicale Suisse. 20:342-344

Subject Terms: Analgesics, 616.0757, 616.89, Humans, Pain Management, Chronic Pain / drug therapy, Ketamine / therapeutic use, Hallucinogens / therapeutic use, 3. Good health

File Description: application/pdf

Access URL: https://archive-ouverte.unige.ch/unige:179115
https://doi.org/10.53738/revmed.2024.20.861.342

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy

Authors: de la Salle, Sara Kettner, Hannes Thibault Lévesque, Julien et al.

Source: Sci Rep
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
de la Salle, S, Kettner, H, Thibault Lévesque, J, Garel, N, Dames, S, Patchett-Marble, R, Rej, S, Gloeckler, S, Erritzoe, D, Carhart-Harris, R & Greenway, K T 2024, 'Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy', Scientific Reports, vol. 14, no. 1, 16524. https://doi.org/10.1038/s41598-024-66817-0
Scientific Reports, vol 14, iss 1

Subject Terms: Adult, Male, Compassionate Use Trials, Canada, Psychotherapy - methods, Science, Palliative treatment, Anxiety, Article, Psychedelics, Humans, Hallucinogens - therapeutic use, name=SDG 3 - Good Health and Well-being, Longitudinal Studies, Prospective Studies, Aged, North American People, Depression - drug therapy, Depression, Distress, Anxiety - drug therapy, Middle Aged, 16. Peace & justice, Psilocybin-assisted psychotherapy, Psilocybin, 3. Good health, Psychotherapy, Psilocybin - therapeutic use, Palliative care, Hallucinogens, Quality of Life, Medicine, Female

File Description: application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/39019922
https://doaj.org/article/bee797d982a14c5db200e188381efc80
https://pure.qub.ac.uk/en/publications/ddae1d7f-2441-415a-9130-4e2d372310ef
https://escholarship.org/content/qt3v68v0sf/qt3v68v0sf.pdf
https://escholarship.org/uc/item/3v68v0sf

Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD)

Authors: Olivier, Berend Olivier, Jocelien D.A.

Source: Advances in Experimental Medicine and Biology ISBN: 9789819744015

Subject Terms: Efficacy, Esketamine, Antidepressive Agents/therapeutic use, Ketamine/therapeutic use, Depressive Disorder, Treatment-Resistant, Treatment-Resistant/drug therapy, Humans, Psilocybin/therapeutic use, NMDA receptor antagonist, Depressive Disorder, Depressive Disorder, Major, Depression, Hallucinogens/therapeutic use, Ayahuasca, Antidepressants, Tolerability, Antidepressive Agents, Psychotomimetic, Psilocybin, 5-HT receptor agonist, Treatment Outcome, Enantiomers, Major/drug therapy, Hallucinogens, Psychedelic, Ketamine, Safety, Treatment-resistant depression, Dissociation

Access URL: https://pubmed.ncbi.nlm.nih.gov/39261423
https://research.rug.nl/en/publications/6abafd35-f6be-4fa5-a2ff-8e30d251dbba
https://hdl.handle.net/11370/6abafd35-f6be-4fa5-a2ff-8e30d251dbba
https://doi.org/10.1007/978-981-97-4402-2_3

Prophylactic action of ayahuasca in a non-human primate model of depressive-like behavior

Authors: Maria Lara Porpino de Meiroz Grilo Geovan Menezes de Sousa Lilían Andrade Carlos de Mendonça et al.

Source: Front Behav Neurosci
Frontiers in Behavioral Neuroscience, Vol 16 (2022)

Subject Terms: Ayahuasca - Resilience, Depressive disorder, Hallucinogens - Therapeutic use, Callithrix, Neurosciences. Biological psychiatry. Neuropsychiatry, 3. Good health, Behavioral Neuroscience, 03 medical and health sciences, 0302 clinical medicine, Depressive disorder - Drug therapy, Callithrix jacchus, XXXXXX - Unknown, Depression - Drug therapy, Ayahuasca - Prophylaxis, prophylaxis, major - Drug therapy, depression model, resilience, ayahuasca, RC321-571

File Description: print; application/pdf

Access URL: https://pubmed.ncbi.nlm.nih.gov/36408451
https://doaj.org/article/ad2ca8cf81c745d3aac31ecab1e288d5

Psychedelic drugs in the treatment of anxiety, depression and addiction / Psykedeliske stoffer i behandling av angst, depresjon og avhengighet

Authors: Kvam, Tor-Morten Stewart, Lowan H Andreassen, Ole A

Source: Tidsskrift for Den Norske Laegeforening. 138(18):1726

Psychedelic-Assisted EMDR Therapy : A Memory-Consolidation Approach to Psychedelic Healing

Authors: Hannah Raine-Smith Jocelyn Rose

Resource Type: eBook.

Subjects: Eye Movement Desensitization Reprocessing, Hallucinogens--therapeutic use, Anesthetics, Dissociative--therapeutic use, Stress Disorders, Traumatic--therapy, Harm Reduction

Categories: PSYCHOLOGY / Psychopathology / Post-Traumatic Stress Disorder (PTSD)

LSD can cure alcoholism / LSD kan bota alkoholism

Authors: Snaprud, Per

Source: Forskning och Framsteg. 47(5-6):46

Psychotherapy with the aid of LSD / Psychotherapy with the aid of LSD

Authors: Madsen, J D Hoffart, A

Source: Nordic Journal of Psychiatry. 50(6):477

Classic psychedelic drugs and their potential therapeutic effect / De klassiske psykedeliske stoffer og deres potentielle terapeutiske virkning

Authors: Bayat, Michael

Source: Ugeskrift for Laeger. 179(26):2302

Efficacy, safety, and tolerability of psychedelics in treatment-resistant depression (TRD)

Authors: Kim, Yong-Ku Olivier, Berend Olivier, Jocelien D A

Source: Olivier, B & Olivier, J D A 2024, Efficacy, safety, and tolerability of psychedelics in treatment-resistant depression (TRD). in Y-K Kim (ed.), Recent Advances and Challenges in the Treatment of Major Depressive Disorder. Advances in experimental medicine and biology, vol. 1456, Springer, pp. 49-66.

Index Terms: Humans, Depressive Disorder, Treatment-Resistant/drug therapy, Hallucinogens/therapeutic use, Ketamine/therapeutic use, Psilocybin/therapeutic use, Antidepressive Agents/therapeutic use, Depressive Disorder, Major/drug therapy, Treatment Outcome, bookPart

URL: https://research.rug.nl/en/publications/6abafd35-f6be-4fa5-a2ff-8e30d251dbba
https://doi.org/10.1007/978-981-97-4402-2_3
https://hdl.handle.net/11370/6abafd35-f6be-4fa5-a2ff-8e30d251dbba
https://pure.rug.nl/ws/files/1099448342/978-981-97-4402-2_3.pdf
https://www.scopus.com/pages/publications/85204098787
info:eu-repo/semantics/altIdentifier/doi/10.1007/978-981-97-4402-2_3
info:eu-repo/semantics/altIdentifier/pmid/39261423
info:eu-repo/semantics/altIdentifier/hdl/https://hdl.handle.net/11370/6abafd35-f6be-4fa5-a2ff-8e30d251dbba
info:eu-repo/semantics/altIdentifier/isbn/978-981-97-4401-5